• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Annals of Long Term Care

  • Follow us on

Search

  • Home
  • ARCHIVES
    • Issues
    • Supplements/Webcasts
  • About Us
    • Mission Statement
    • Editorial Description
    • Editorial Board
    • Publishing Staff
    • Our Partners
    • AGS Affiliations
    • Reprints/Permissions
  • SUBMIT
    • Author Guidelines
    • Copyright Transfer Form
    • Author Disclosure Form
    • Submit Now
  • CONTACT
  • ADVERTISING
    • Print Rate Card
    • Online Rate Card
    • Classified Rate Card
    • Sales Contacts
  • Supplements/Special Projects
  • Journal News
  • WEBCASTS
    • Facing Postherpetic Neuralgia in LTC
    • Treatment for Postherpetic Neuralgia Pain
    • Case Study—LTC Patient Suffering from PHN

Medication Reconciliation and Seamless Care in the Long-Term Care Setting

  • Tue, 11/10/09 - 9:27am
  • 0 Comments
  • 5704 reads
Citation: 

Pages 36 - 40

Author(s): 

Neil J. MacKinnon, PhD, FCSHP, Robert M. Kaiser, MD, MHSc, Paula Griswold, MS, and Alice Bonner, PhD, RN

The evidence in support of medication reconciliation has increased rapidly in recent years, while the need for an improved medication-use system in the LTC setting remains. This article describes the essential elements of medication reconciliation and its application to the LTC setting. First, a case presentation depicts some of the typical clinical problems involving medications that face residents and clinicians in this setting and during transitions of care. Second, a brief literature review of medication reconciliation follows, with a special emphasis on the LTC setting. Third, a practical real-life example of adopting this service in several facilities in one state, the Nursing Home Medication Safety Project in Massachusetts, is reviewed. Finally, suggested strategies for implementation are presented, including implications for clinicians. (Annals of Long-Term Care: Clinical Care and Aging 2009;17[11]:36-40)

Clinical Scenario

Mr. H is an 88-year-old white man who lives by himself in the house he shared with his wife of over 50 years, until her death two years ago. He is generally alert and oriented and can make his immediate needs known. He is fiercely independent. Despite being forgetful and occasionally confused, Mr. H refuses to accept much help from his two sons and daughter, who live nearby. He is not fond of seeing doctors and often misses appointments. He reluctantly takes medications and may skip them for several days in a row because he feels he is taking too many pills. Mr. H’s medical problems include congestive heart failure, atrial fibrillation, hypertension, chronic obstructive pulmonary disease, degenerative joint disease, falls, dizziness, insomnia, and depression. His prescribed medications include: regularly-scheduled digoxin, warfarin, metoprolol, albuterol metered-dose inhaler, and fluoxetine, as well as trazodone as needed for sleep.

One day, Mr. H’s daughter comes to pick him up for an appointment but he does not answer the door. She finds him lying on the floor moaning. She calls 911, and he is taken to the emergency room, where he is diagnosed with a right hip fracture and mild dehydration. He is admitted and undergoes an open-reduction internal fixation procedure that night. His post-operative course is mostly uneventful, but he becomes confused on post-op day 2; he is administered haloperidol intravenously with good results. He also develops a low-grade temperature. The next day, he is discharged from the hospital and admitted to a skilled nursing facility (SNF) for rehabilitation. His discharge medications include: (1) haloperidol as needed for delirium; (2) a higher dose of digoxin, since on hospital admission, his digoxin level was < 0.1; and (3) meclizine as needed for dizziness because Mr. H’s daughter told the hospital staff about her father having been lightheaded at home prior to his admission.

Mr. H arrives on the subacute unit at the nursing home at 5:00 PM on Friday evening; he is the fourth admission that afternoon. He had been in the hospital for 3 days and is now more confused. He is taking 10 medications, including a proton pump inhibitor, ibuprofen, meclizine, senna, docusate, and haloperidol. Mr. H has an unsteady gait and complains of dizziness upon standing.

Mr. H’s confusion increases, and he has a fall related to weakness on his fourth day in the SNF. Laboratory studies reveal a digoxin level of 3.5 (reference range, 0.8-2.4 ng/mL), Hgb/Hct of 8/25 (reference range, 14-18 g/dL/ 39-54%), INR of 5.1 (reference range, 2.0-3.0), and BUN of 70 (reference range, 6-23 mg/dL). He is transferred back to the hospital and diagnosed with an upper gastrointestinal bleed, dehydration, and digoxin toxicity. After 3 days, he is stable and transferred back to the SNF.

Clinical Scenario Questions:

image description image description
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • next ›
  • last »



Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

LATEST NEWS

  • FDA Finally Approves Once-Weekly Type 2 Diabetes Treatment
    [Amylin] 1-31-12
  • FDA approves Voraxaze to treat patients with toxic methotrexate levels
    [FDA] 1-17-12
  • FDA approves first generic version of cholesterol-lowering drug Lipitor
    [FDA] 11-30-11
  • AHRQ Awards $34 Million To Expand Fight Against Healthcare-Associated Infections
    [AHRQ] 11-17-11
more »

Poll

Are nutritional supplements underutilized in long-term care?:

Classified/Recruitment Opportunities

  • Advertise Your Job Here
more »

ALTC Blogs

How to Create Collegiality in a Difference of Opinion: Part 1

Neil Baum MD
2/3/12 | 0 Comments | 12 reads

Dutasteride vs Low Grade Prostate Cancer

Alvin B Lin MD FAAFP
1/31/12 | 0 Comments | 37 reads

Finding “Dr. Right” For Your Practice

Neil Baum MD
1/30/12 | 0 Comments | 40 reads
more »
banner banner banner banner banner
HMP Communications © 2012 HMP Communications
  • Home
  • About Us
  • Other Publications
  • Contact Us
  • Privacy Policy

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. © 2012 HMP Communications